Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← Analysis & Perspectives
AvalereFebruary 12, 2025

340B Program Cost States $2 Billion in Foregone Medicaid Rebates in 2023, Analysis Finds

When 340B covered entities shift hospital outpatient drug claims from Medicaid into the 340B program, state Medicaid programs lose access to manufacturer rebates—totaling an estimated $2 billion in 2023 alone. The analysis highlights how rapid 340B growth, particularly among rural referral centers and disproportionate share hospitals, creates budget pressure for state Medicaid programs while patients may not receive direct cost-sharing relief. This matters for MCO compliance and finance teams navigating drug pricing arrangements and state directors managing pharmacy budgets under constrained fiscal conditions.

Pharmacy · Finance · Managed Care

Read the full analysis at Avalere →

This is outside commentary from Avalere, not part of Medicaid Monitor's independently scored news coverage.

Share this

More from Avalere

← Analysis & Perspectives

Get the daily briefing.